FoLix® Fractional Laser Hair Restoration
A non‑invasive, drug‑free way to stimulate thicker, fuller‑looking hair — now at Bauman Medical. FoLix is the first FDA‑cleared proprietary fractional laser designed specifically for hair growth support in adults with pattern hair loss.
FoLix® is a 1565 nm non‑ablative fractional laser that delivers precise micro‑thermal energy beneath the scalp surface. These controlled micro‑zones trigger a regenerative wound‑healing response that supports follicle activity and hair thickening — while keeping the skin’s surface intact for comfort and no social downtime [Lumenis, 2024; Perper, 2017].
- Who it’s for: Men and women with mild‑to‑moderate androgenetic alopecia (pattern hair loss)
- Session length: ~30 minutes
- Series: Typically 4–6 monthly sessions, then periodic maintenance
- Comfort: Mild warmth/tingling; no needles or anesthesia required
- Clearance: FDA‑cleared to improve the appearance of scalp hair (Fitzpatrick skin types I–IV)
FoLix is well‑tolerated. The most common effects are mild, temporary redness or warmth. Rarely, short‑term shedding of weak hairs can occur as follicles reset cycling. No systemic side effects are expected. As with all energy devices, proper selection and technique minimize risks [Perper, 2017; Day, 2022].
- Hair Transplant Surgery (FUE/FUT): Transplant relocates follicles to bald areas; FoLix stimulates existing follicles in thinning zones. Many patients use FoLix to maintain and enhance native hair, either before or after transplant.
- Medications (minoxidil, finasteride, etc.): Effective for many; FoLix offers a drug‑free in‑office alternative or adjunct, especially for patients who cannot tolerate or prefer to avoid meds.
- At‑home LLLT caps & topicals: Helpful but require strict adherence; FoLix delivers clinic‑grade energy with consistent dosing.
- In‑office non‑surgical (PRP, exosomes, TED): FoLix is needle‑free and can be combined with biologics or trans‑epidermal delivery strategies for synergistic results [Suchonwanit, 2019].
Your plan may include:
- FoLix + PRP or biologics/exosomes for dual regenerative signaling
- FoLix + low‑dose oral/topical medications for stabilization and stimulation
- FoLix + nutraceuticals (e.g., targeted hair supplements)
- FoLix + LLLT for in‑between session support
- FoLix prior to FUE transplant for improved healing and hair growth postop
Below are real FoLix before‑and‑after examples that illustrate the type of improvement some patients have experienced. These images are representative only; individual results vary.
Female FoLix Results
A
Male FoLix Results
A
Results You Can Measure
We track progress with trichoscopy, hair‑mass index, and standardized photography. Published studies report meaningful improvements in hair density, terminal hair counts, and shaft diameter after a treatment series [Qu, 2024; Dai, 2024; Day, 2022; Suchonwanit, 2019]. Individual results vary.
Is FoLix painful? Most patients report only mild warmth/tingling.
How many sessions will I need? Typically 4–6 to start, then maintenance.
Can it replace a transplant? FoLix is not a replacement for areas with no hair; it’s excellent for thinning zones and as a complement to transplantation.
Is there downtime? No. Expect temporary pinkness only.
When will I see results? Early improvements often appear by 8–12 weeks, with continued gains through 3–6 months.
Can I combine it with my current regimen? Yes — many do, and evidence suggests additive benefits with topicals, PRP, LaserCaps and other therapies [Suchonwanit, 2019; Dai, 2024].
Ready to get started? Call 561‑394‑0024 or request a consultation at BaumanMedical.com.
Selected Scientific References
- Lumenis. (2024). FoLix: FDA‑cleared fractional laser hair restoration. https://lumenis.com/aesthetics/products/folix
- Perper M, et al. (2017). Fractional lasers for hair regrowth: A review. Lasers Med Sci. https://pubmed.ncbi.nlm.nih.gov/28812164/
- Suchonwanit P, et al. (2019). Fractional erbium‑glass laser + minoxidil vs minoxidil alone (split‑scalp RCT). Lasers Med Sci. https://link.springer.com/article/10.1007/s10103-019-02766-4
- Qu Y, et al. (2024). 1565‑nm fractional laser vs 5% minoxidil (RCT). J Cosmet Dermatol. https://pubmed.ncbi.nlm.nih.gov/38087122/
- Day D, et al. (2022). Non‑ablative Er:YAG case series with high satisfaction and no AEs. J Cosmet Dermatol. https://pubmed.ncbi.nlm.nih.gov/34435735/
- Dai R, et al. (2024). Er:YAG + meds vs meds alone (192‑patient cohort). Lasers Med Sci. https://pubmed.ncbi.nlm.nih.gov/38724798/
FoLix® is a registered mark of Lumenis®. FoLix is FDA‑cleared to improve the appearance of scalp hair in adults with androgenetic alopecia (Fitzpatrick I–IV). Individual results vary. Medical evaluation required to determine candidacy.